Epcoritamab (Epkinly)

epcoritamab · Genmab and AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epcoritamab (Epkinly), covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome [Phase 1]